Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.

Sharkovska, Yuliya

Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. [electronic resource] - Clinical laboratory 2011 - 507-15 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1433-6510


Acute Kidney Injury--drug therapy
Albuminuria--etiology
Animals
Aspartic Acid Endopeptidases--antagonists & inhibitors
Constriction
Disease Models, Animal
Drug Evaluation, Preclinical
Endothelin-Converting Enzymes
Enzyme Inhibitors--pharmacology
Glomerulosclerosis, Focal Segmental--etiology
Hypertension--chemically induced
Kidney--blood supply
Kidney Failure, Chronic--drug therapy
Male
Metalloendopeptidases--antagonists & inhibitors
NG-Nitroarginine Methyl Ester--toxicity
Nephrectomy
Neprilysin--antagonists & inhibitors
Rats
Rats, Wistar
Reperfusion Injury--complications